Abstract | OBJECTIVE: METHOD: A total of 162 persistent non- allergic rhinitis cases with moderate to severe nasal obstruction were randomized to treatment with the following: the combination therapy or nasal corticosteroids monotherapy. Efficacy was assessed by change from baseline in nasal obstruction score at week 2 and week 6 visits. The perceptions of global treatment satisfaction(convenience, side effects, cost and effectiveness) in both groups were analyzed. RESULT: In both groups, the nasal obstruction score assessment descended significantly at week 2 and week 6 visits versus at baseline (all P < 0.01). At week 2 and week 6 visits, the nasal obstruction score in the combination therapy groups were significantly improved than that in nasal corticosteroids monotherapy groups (all P < 0.01). The perceptions of global treatment satisfaction in the combination therapy groups were significantly better (P < 0.05). CONCLUSION:
|
Authors | Limin Guo, Xicai Sun, Juanmei Yang, Juan Liu, Dehui Wang |
Journal | Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
(Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Vol. 29
Issue 3
Pg. 243-5, 251
(Feb 2015)
ISSN: 2096-7993 [Print] China |
PMID | 26012297
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Adrenal Cortex Hormones
- Histamine H1 Antagonists
- Phthalazines
- azelastine
|
Topics |
- Administration, Intranasal
- Adrenal Cortex Hormones
(therapeutic use)
- Drug Therapy, Combination
- Histamine H1 Antagonists
(therapeutic use)
- Humans
- Nasal Obstruction
- Phthalazines
(therapeutic use)
- Rhinitis
(drug therapy)
|